J.-P. Brandel

3.5k total citations
22 papers, 2.0k citations indexed

About

J.-P. Brandel is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, J.-P. Brandel has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Neurology and 8 papers in Neurology. Recurrent topics in J.-P. Brandel's work include Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). J.-P. Brandel is often cited by papers focused on Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). J.-P. Brandel collaborates with scholars based in France, United States and United Kingdom. J.-P. Brandel's co-authors include Yves Agid, Irene Litvan, Gregor K. Wenning, R. K. B. Pearce, John J. Bartko, К. Ray Chaudhuri, Marc Verny, K. A. Jellinger, Ann C. McKee and Eugene C. Lai and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Brain.

In The Last Decade

J.-P. Brandel

21 papers receiving 1.9k citations

Peers

J.-P. Brandel
Alison J. E. Green United Kingdom
Carolyn Orr Australia
Jay A. van Gerpen United States
Amanda Najjar United States
Alison J. E. Green United Kingdom
J.-P. Brandel
Citations per year, relative to J.-P. Brandel J.-P. Brandel (= 1×) peers Alison J. E. Green

Countries citing papers authored by J.-P. Brandel

Since Specialization
Citations

This map shows the geographic impact of J.-P. Brandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Brandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Brandel more than expected).

Fields of papers citing papers by J.-P. Brandel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Brandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Brandel. The network helps show where J.-P. Brandel may publish in the future.

Co-authorship network of co-authors of J.-P. Brandel

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Brandel. A scholar is included among the top collaborators of J.-P. Brandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Brandel. J.-P. Brandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandel, J.-P. & Stéphane Haı̈k. (2016). Malattie da prioni o encefalopatie spongiformi trasmissibili. 16(2). 1–21.
2.
Moda, Fabio, Pierluigi Gambetti, Silvio Notari, et al.. (2014). Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease. New England Journal of Medicine. 371(6). 530–539. 135 indexed citations
3.
Xiao, Xiangzhu, Jue Yuan, Stéphane Haı̈k, et al.. (2013). Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease. PLoS ONE. 8(3). e58786–e58786. 31 indexed citations
4.
Brandel, J.-P., Laurène Peckeu, & Stéphane Haı̈k. (2013). The French surveillance network of Creutzfeldt–Jakob disease. Epidemiological data in France and worldwide. Transfusion Clinique et Biologique. 20(4). 395–397. 23 indexed citations
5.
Diack, Abigail B., Diane Ritchie, Matthew Bishop, et al.. (2012). Constant Transmission Properties of Variant Creutzfeldt-Jakob Disease in 5 Countries. Emerging infectious diseases. 18(10). 1574–1579. 17 indexed citations
6.
Brandel, J.-P., et al.. (2009). Le réseau de surveillance de la maladie de Creutzfeldt-Jakob. Revue Neurologique. 165(8-9). 684–693. 8 indexed citations
7.
Brandel, J.-P., et al.. (2007). Impact de la maladie de Parkinson sur la qualité de vie des conjoints de patients. Une étude qualitative. Revue Neurologique. 163(8-9). 801–807. 10 indexed citations
8.
Rivaud‐Péchoux, S., Marie Vidailhet, J.-P. Brandel, & Bertrand Gaymard. (2006). Mixing pro- and antisaccades in patients with parkinsonian syndromes. Brain. 130(1). 256–264. 71 indexed citations
9.
Brandel, J.-P., et al.. (2006). Épidémiologie de la variante de la maladie de Creutzfeldt-Jakob en France. Transfusion Clinique et Biologique. 13(5). 304–306. 4 indexed citations
10.
Ayache, Nicholas, Éric Bardinet, Stéphane Haı̈k, et al.. (2006). Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain-definition and evaluation of new MRI-based ratios. IEEE Transactions on Medical Imaging. 25(8). 1052–1067. 6 indexed citations
11.
Hauw, J.‐J., V. Sazdovitch, Jean Laplanche, et al.. (2000). Neuropathologic variants of sporadic Creutzfeldt–Jakob disease and codon 129 of PrP gene. Neurology. 54(8). 1641–1646. 53 indexed citations
12.
Brown, Paul, Michael Preece, J.-P. Brandel, et al.. (2000). Iatrogenic Creutzfeldt–Jakob disease at the millennium. Neurology. 55(8). 1075–1081. 360 indexed citations
13.
d’Aignaux, Jérôme Huillard, Dominique Costagliola, Jean Maccario, et al.. (1999). Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France. Neurology. 53(6). 1197–1197. 62 indexed citations
14.
Litvan, Irene, Vicky Booth, Gregor K. Wenning, et al.. (1998). Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. Journal of Neural Transmission. 105(2-3). 217–227. 32 indexed citations
15.
Litvan, Irene, Ann Macintyre, Christopher G. Goetz, et al.. (1998). Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies. Archives of Neurology. 55(7). 969–969. 233 indexed citations
16.
Beaudry, P., Philip Cohen, J.-P. Brandel, et al.. (1998). 14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease. Dementia and Geriatric Cognitive Disorders. 10(1). 40–46. 126 indexed citations
17.
Litvan, Irene, Yves Agid, Christopher G. Goetz, et al.. (1997). Accuracy of the Clinical Diagnosis of Corticobasal Degeneration. Neurology. 48(1). 119–125. 289 indexed citations
18.
Litvan, Irene, Yves Agid, Joseph Jankovic, et al.. (1997). What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 49(1). 62–69. 55 indexed citations
19.
Litvan, Irene, Yves Agid, Joseph Jankovic, et al.. (1996). Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 46(4). 922–930. 266 indexed citations
20.
Laplanche, Jean, N. Delasnerie–Lauprêtre, J.-P. Brandel, et al.. (1994). Molecular genetics of prion diseases in France. Neurology. 44(12). 2347–2347. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026